NG
NervGen Pharma Corp. Common stock (NGEN)
NASDAQ·Healthcare·Biotechnology
$3.91
+1.43%
Mkt Cap $317.25M
Next Earnings
In 15 daysThu, May 14, 2026
EPS Estimate
-$0.07
3 analysts
Revenue Estimate
$4.50K
Last quarter: missed by -125.77% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$317.25M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.61